Sponsor Pipeline

Fondazione Italiana Linfomi - ETS Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
33
Active Trials
18
Recruiting
5
Phase 3
5
Disease Areas
Active Trials by Phase
Phase 3
5
Phase 2
8
Phase 1/2
2
Not specified
18
Active Trials — top 25 of 33
NCT IDTitleConditionStatus
Phase 3
NCT04442412 Prephase Treatment With Prednisone +/- Vitamin D Supplementation Followed by… Diffuse Large B-Cell Lymphoma Recruiting
NCT05929222 Comparison Between Local Radiotherapy Alone or Combined With Obinutuzumab in Early Stage… Follicular Lymphoma Recruiting
NCT02390869 Rituximab and Lenalidomide vs Rituximab Alone as Maintenance After R-chemoterapy for… Lymphoma, Follicular Active, Not Recruiting
NCT07256158 PET Guided Dose Reduction for InvOlved Site Radiotherapy In Early sTage Unfavourable… Hodgkin Lymphoma Not Yet Recruiting
NCT05058404 Shortened vs Standard Chemotherapy Combined With Immunotherapy for the Initial Treatment… Follicular Lymphoma Active, Not Recruiting
Phase 2
NCT05977673 Efficacy and Safety of Frontline Tislelizumab in Patients With de Novo Hodgkin Lymphoma… Hodgkin Lymphoma Recruiting
NCT06835530 A Combination of Rituximab and CC-99282 as Front-line Therapy for Older Frail Patients… Diffuse Large B Cell Non-Hodgkin Lymphoma Recruiting
NCT05249959 Consolidation With Loncastuximab Tesirine After a Short Course of Immunochemotherapy in… Relapsed Mantle Cell Lymphoma Recruiting
NCT06492837 Study With Mosunetuzumab and Zanubrutinib in R/R Follicular Lymphoma Patients Follicular Lymphoma Recruiting
NCT04915248 Study to Evaluate Combined Treatment of Daratumumab, Bortezomib and Dexamethasone in PBL… Plasmablastic Lymphoma Recruiting
NCT07453095 Study With Glofitamab in Patients With MCL and Inadequate Response or Relapse Following… Mantle Cell Lymphoma Recruiting
NCT07207785 PirtobrUtinib as Frontline Therapy for Elderly Unfit/Frail Patient With MAntle Cell… Mantle Cell Lymphoma Not Yet Recruiting
NCT03731234 Ibrutinib + R-CHOP Followed by Ibrutinib Maintenance DLBCL Active, Not Recruiting
Phase 1/2
NCT05300282 Study of Atezolizumab Plus BEGEV Regimen in Relapsed or Refractory Hodgkin's Lymphoma… Relapsed or Refractory Hodgkin's Lymphoma Recruiting
NCT02223208 Ro Plus CHOEP as First Line Treatment Before HSCT in Young Patients With Nodal Peripheral… Peripheral T-cell Lymphomas (PTCL) Active, Not Recruiting
Not specified
NCT06588868 Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma Cutaneous T Cell Lymphoma Recruiting
NCT06781359 Study on Plasmablastic Lymphoma Patients Plasmablastic Lymphoma Recruiting
NCT06156774 SARcopenia and Simplified Geriatric Assessment in Lymphoma Patients Undergoing CAR-T Cell… Non-hodgkin Lymphoma,B Cell Recruiting
NCT05816850 Multilayer Biological Characterization of Advanced Follicular Lymphoma: a Translational… Follicular Lymphoma Recruiting
NCT06008691 A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal… Non-Hodgkin Lymphoma, B-cell Recruiting
NCT06588205 Exploring the Clinical Impact of MYC Aberrations and Their Relationship With… Diffuse Large B Cell Lymphoma Recruiting
NCT05819528 Primary Cardiac Lymphoma: Italian Multicenter Experience Primary Cardiac Lymphoma Recruiting
NCT05524298 Quality Of Life On Elderly Patients With Low Grade Non-Hodgkin Lymphoma Low Grade Non-Hodgkin's Lymphoma, Adult Recruiting
NCT05934084 Lifestyles Implemented-Survivorship Care Plan In Lymphoma Survivors Classical Hodgkin Lymphoma Recruiting
NCT07046663 Long-term Assessment of Chlormethine Gel in Mycosis Fungoides Cutaneous T-Cell Lymphoma/Mycosis Fungoides Not Yet Recruiting
See all 33 active Fondazione Italiana Linfomi - ETS trials with filters →
Disease Areas
Get alerts when Fondazione Italiana Linfomi - ETS's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free